A2213712
Brij® L4 , 99.5% , 9002-92-0
Synonym(s):
Brij 35;Polidocanol;Lauromacrogol;Polyethylene glycol dodecyl ether;Coceth-10
CAS NO.:9002-92-0
Empirical Formula: C58H118O24
Molecular Weight: 1199.55
MDL number: MFCD00043375
EINECS: 500-002-6
Pack Size | Price | Stock | Quantity |
50ML | RMB95.20 | In Stock |
|
250ML | RMB263.20 | In Stock |
|
1L | RMB799.20 | In Stock |
|
5L | RMB3199.20 | In Stock |
|
25L | RMB11199.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 41-45 °C(lit.) |
Boiling point: | 100 °C(lit.) |
Density | 0.99 g/mL±0.002 g/mL at 20 °C |
vapor pressure | <1 mm Hg ( 20 °C) |
refractive index | n |
Flash point: | >230 °F |
storage temp. | Store below +30°C. |
solubility | H2O: 40 mg/mL at 20 °C, clear, colorless |
pka | 0[at 20 ℃] |
form | Waxy Pellets |
color | White |
PH | 5.5-7.0 (100g/l, H2O, 20℃) |
Odor | Odorless |
PH Range | 5.5 - 7.5 |
Water Solubility | soluble |
FreezingPoint | 35.0 to 40.0 ℃ |
Merck | 14,7558 |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents. |
LogP | 2.26 at 25℃ |
Description and Uses
Brij L23 is a a pharmaceutical compound used in the schlerotherapy treatments, in those suffering from blood vessel malformations and mutations.
Safety
Symbol(GHS) | GHS07,GHS09 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H410 |
Precautionary statements | P264-P270-P273-P301+P312-P302+P352-P305+P351+P338 |
Hazard Codes | Xn,Xi |
Risk Statements | 22-41-36/37/38-38-37/38-36 |
Safety Statements | 26-39-37/39-36/37/39-36-24/25 |
RIDADR | UN 3082 9/PG 3 |
WGK Germany | 3 |
RTECS | MD0875000 |
F | 3 |
TSCA | Yes |
HS Code | 34021300 |
HS Code | 38220000 |
Toxicity | LD50 in mice (mg/kg): 1170 orally, 125 i.v. (Zipf) |